Evotec SE, DE0005664809

Evotec stock after-hours at EUR 2.98: plus 4.56 percent versus prior close

Published on 09/29/2026 at 22:07 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS

Evotec stock was at EUR 2.98 after-hours at 10:06 p.m. CEST on September 29, 2026, up 4.56 percent versus the Lang & Schwarz prior close. The company announced a leadership transition.

Fotorealistisches Pharma-Labor mit Wissenschaftlern bei Wirkstoffscreening in moderner Biotech-Anlage
Fotorealistisches Pharma-Labor symbolisiert Wirkstoffforschung von Evotec SE, ISIN DE0005664809, moderner Biotech-Standort Hamburg, Illustration mit AI erstellt.

Evotec stock was at EUR 2.98 after-hours at 10:06 p.m. CEST on September 29, 2026, according to Lang & Schwarz. The price was up 4.56 percent versus the Lang & Schwarz prior close of EUR 2.85.

Evotec announces science leadership change

Evotec SE announced on September 29, 2026, that Chief Scientific Officer Dr. Cord Dohrmann will step down effective September 30, 2026. The company said the decision was made by mutual consent. The announcement identified Evotec’s listings as Frankfurt Prime Standard: EVT and Nasdaq: EVO. Deutsche Börse published the issuer announcement.

Dohrmann has served as Evotec’s Chief Scientific Officer and as a member of its Management Board since 2010. Evotec said the search for his replacement is ongoing. Chief Executive Officer Christian Wojczewski thanked Dohrmann for his contributions during his 16 years with the company. PR Newswire carried the company release.

Disclaimer...

en | DE0005664809 | EVOTEC SE | boerse | 70200864 | bgmi